CORONAVIRUS/With new data, UBI Asia hoping for review of vaccine EUA application
Taiwan-based United Biomedical Inc. (UBI) Asia is planning to reapply for emergency use authorization (EUA) for its COVID-19 vaccine based on what it described as very strong data after giving clinical trial subjects a third